Treatment of urinary tract infections with cephalexin.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002493:Central Nervous System Diseases / Q000139:chemically induced; D002511:Cephalosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D003298:Coombs Test; D004802:Eosinophilia / Q000139:chemically induced; D005260:Female; D006452:Hemoglobinometry; D006801:Humans; D007677:Kidney Function Tests; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D011704:Pyelonephritis / Q000188:drug therapy; D012737:Sex Factors; D013921:Thrombocytopenia / Q000139:chemically induced; D014060:Tongue Diseases / Q000139:chemically induced; D014552:Urinary Tract Infections / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced
D002511:Cephalosporins